Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Melanotan-I

Afamelanotide, MT-I, [Nle4-D-Phe7]-α-MSH, Scenesse, CUV-1647

Quick Stats
Studies 225
Trials 100
Score 1
1996 pubmed

Human epidermal melanocyte and keratinocyte melanocortin receptors: visualization by melanotropic peptide conjugated microspheres (latex beads).

Jiang. J J; Sharma. S D SD; Hruby. V J VJ; Bentley. D L DL; Fink. J L JL; Hadley. M E ME

Key Findings

  • Human epidermal melanocytes and keratinocytes both display melanocortin receptors on their surface.
  • Binding of the hormone‑coated beads is highly specific and can be blocked by the free peptide or disrupted by chemical reduction.
  • Non‑melanocyte cells (e.g., breast cancer, lung cancer, fibroblasts) do not bind the beads, confirming cell‑type specificity.

Practical Outcomes

  • For most biohackers, this work is mainly a technical validation that melanocortin receptors are present on skin cells, but it does not provide dosing guidance, safety data, or direct performance benefits. It suggests that any future skin‑tanning or pigment‑modulating protocols using melanotan‑I would need to consider that keratinocytes also respond, potentially affecting skin health.

Summary

The study shows that a synthetic version of the hormone alpha‑MSH (called [Nle4,D-Phe7]alpha‑MSH) can be attached to tiny latex beads, and these beads stick specifically to skin cells that have melanocortin receptors – mainly melanocytes (the cells that make pigment) and also keratinocytes. The binding can be blocked by the free hormone, proving the interaction is specific.

Abstract

The objectives of this research were to determine whether melanocortin receptors are characteristic (constant) membrane markers of human epidermal melanocytes. Methodologies were developed to visualize melanotropin receptors by scanning electron microscopy (SEM). Multiple copies (up to a hundred) of [Nle4,D-Phe7]alpha-MSH, a superpotent analog of alpha-melanocyte stimulating hormone (alpha-MSH), were conjugated to a macromolecular carrier (latex beads: microspheres). Incubation in the presence of the melanotropin-conjugated microspheres resulted in binding of human normal epidermal melanocytes to the beads. Almost every (possibly all) melanocyte possesses melanocortin receptors as visualized by SEM. Specificity of binding of the macromolecular conjugate was demonstrated by several studies: 1) Binding of melanocytes to the microspheres was specific since it could be blocked by prior incubation of the cells in the presence of the unconjugated hormone analog; 2) microspheres lacking bound ligand did not bind to the melanocytes; 3) microspheres that were first treated with reducing agents (e.g., dithiothreitol) did not subsequently bind to melanocytes; 4) another peptide hormone ligand (e.g., a substance-P analog) attached to the latex beads failed to bind to the cells; 5) B16/F10 mouse melanoma cells known to express melanocortin receptors bound to the microspheres; and 6) cells of nonmelanocyte origin (e.g., mammary cancer cells, small-cell lung cancer cells, fibroblasts) did not bind to the macromolecular conjugate. One exception was that human epidermal keratinocytes also expressed melanocortin receptors as determined by all the criteria established above for epidermal melanocytes. Thus, cell specific melanocortin receptors appear to be characteristic cell surface markers of epidermal melanocytes and keratinocytes.

Study Information

Provider

pubmed

Year

1996

DOI

10.1111/j.1600-0749.1996.tb00113.x